TW202342496A - 介白素-23受體之肽抑制劑及其醫藥組成物 - Google Patents

介白素-23受體之肽抑制劑及其醫藥組成物 Download PDF

Info

Publication number
TW202342496A
TW202342496A TW112103335A TW112103335A TW202342496A TW 202342496 A TW202342496 A TW 202342496A TW 112103335 A TW112103335 A TW 112103335A TW 112103335 A TW112103335 A TW 112103335A TW 202342496 A TW202342496 A TW 202342496A
Authority
TW
Taiwan
Prior art keywords
composition
amount
formula
compound
solvate
Prior art date
Application number
TW112103335A
Other languages
English (en)
Chinese (zh)
Inventor
杰拉爾丁 布洛克斯
大衛 貝斯林
克萊拉 安杜克斯坎圖
克里斯托弗 戴多布拉勒
吉爾達斯 丹尼奧
朱斯蒂諾 迪普雷托羅
盧茲卡 克拉克歐維克
娜塔莉 梅藤斯
賽哈爾 帕塔爾
貝蒂 派德森
戈帕爾 拉詹
大軍 孫
菲利浦 費南德斯
Original Assignee
比利時商健生藥品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 比利時商健生藥品公司 filed Critical 比利時商健生藥品公司
Publication of TW202342496A publication Critical patent/TW202342496A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
TW112103335A 2022-02-01 2023-01-31 介白素-23受體之肽抑制劑及其醫藥組成物 TW202342496A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263305631P 2022-02-01 2022-02-01
US63/305,631 2022-02-01

Publications (1)

Publication Number Publication Date
TW202342496A true TW202342496A (zh) 2023-11-01

Family

ID=85556753

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112103335A TW202342496A (zh) 2022-02-01 2023-01-31 介白素-23受體之肽抑制劑及其醫藥組成物

Country Status (13)

Country Link
EP (1) EP4472999A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506374A (cg-RX-API-DMAC7.html)
KR (1) KR20240137102A (cg-RX-API-DMAC7.html)
CN (1) CN118829647A (cg-RX-API-DMAC7.html)
AU (1) AU2023215245A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250172A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002263A1 (cg-RX-API-DMAC7.html)
IL (1) IL314629A (cg-RX-API-DMAC7.html)
MX (1) MX2024009477A (cg-RX-API-DMAC7.html)
PE (1) PE20241895A1 (cg-RX-API-DMAC7.html)
TW (1) TW202342496A (cg-RX-API-DMAC7.html)
UY (1) UY40135A (cg-RX-API-DMAC7.html)
WO (1) WO2023150500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250139359A (ko) 2023-01-31 2025-09-23 얀센 파마슈티카 엔브이 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법
EP4780453A1 (en) * 2023-09-21 2026-07-29 Janssen Pharmaceutica NV Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis
WO2025151385A1 (en) * 2024-01-08 2025-07-17 Janssen Pharmaceutica Nv Peptide inhibitors of interleukin-23 receptor and uses thereof
WO2025163534A1 (en) * 2024-01-31 2025-08-07 Janssen Pharmaceutica Nv Crystal form of a peptide inhibitor of interleukin-23 receptor
WO2025243217A1 (en) * 2024-05-22 2025-11-27 Janssen Pharmaceutica Nv Crystal forms of peptide molecules
WO2026106852A1 (en) * 2024-11-15 2026-05-21 Janssen Pharmaceutica Nv Methods of using interleukin-23 receptor antagonists
WO2026114760A1 (en) * 2024-11-29 2026-06-04 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946150B2 (en) 2011-06-14 2015-02-03 Medical Diagnostic Laboratories, LLC. Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
SMT202500254T1 (it) 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie

Also Published As

Publication number Publication date
UY40135A (es) 2023-08-31
KR20240137102A (ko) 2024-09-19
WO2023150500A1 (en) 2023-08-10
CN118829647A (zh) 2024-10-22
AU2023215245A1 (en) 2024-09-19
MX2024009477A (es) 2024-11-08
PE20241895A1 (es) 2024-09-19
CL2024002263A1 (es) 2025-02-07
EP4472999A1 (en) 2024-12-11
CA3250172A1 (en) 2023-08-10
JP2025506374A (ja) 2025-03-11
IL314629A (en) 2024-09-01

Similar Documents

Publication Publication Date Title
JP7397239B2 (ja) インターロイキン-23受容体のペプチド阻害剤の組成物
KR20240137102A (ko) 인터류킨-23 수용체의 펩티드 억제제 및 이의 약제학적 조성물
EP4031109B1 (en) Extended release dosage forms for tyk2 inhibitors
CN101466359B (zh) 快速释放的对乙酰氨基酚片
TWI389691B (zh) 可口服且具有活性成分快速釋出之固態醫藥劑型
JP2016509990A (ja) 非晶質トルバプタンを含有する経口投与懸濁剤
CN101553466B (zh) 化合物的晶形
KR20230002361A (ko) 카파 오피오이드 수용체 효능제의 올리고당 제형
KR101084659B1 (ko) 에스오메프라졸의 과립 및 그 장용성 과립의 제조방법
JP2026505072A (ja) インターロイキン-23受容体の結晶性ペプチド阻害剤を調製するための方法
CN102274223B (zh) 含替米沙坦和氨氯地平的复方制剂
TWI918738B (zh) 布瓦西坦藥物組合物、其製備方法及應用
WO1999039730A1 (en) Oral preparations containing peptides promoting the secretion of growth hormone
HK40117634A (en) Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof
CN102711763A (zh) 口服用医药组合物
CN102949358A (zh) 一种米诺膦酸片剂及其制备方法
JP2023522756A (ja) セリアック病のためのピリジノン誘導体の全身性製剤
JP2023523289A (ja) Tg-2関連疾患のためのピリジノン誘導体における全身性製剤
JPH1045619A (ja) 成長ホルモン分泌促進ペプチド含有経口製剤
TW201924661A (zh) 含有非馬沙坦的固體分散體
JP2025524357A (ja) 多数の顆粒
HK40092077A (en) Compositions of peptide inhibitors of interleukin-23 receptor
WO2023044024A9 (en) Novel ph dependent coating drug delivery system
JP5044572B2 (ja) イミダゾリルアルキル−ピリジンの安定な投薬製剤